- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Orexo AB ADR (ORXOY)
Assess today's live Orexo AB ADR (ORXOY) share price, performance and insights using our live OTC Markets: ORXOY stock exchange data.
Analyse the historical data and Orexo AB ADR share price performance charts on this page. Our technical summary section provides analysis on Orexo ADR share price buy/sell indicators using real-time data (or discuss the Orexo ADR (ORXOY) stock price today with other investors in the Orexo ADR OTC share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current OTC ORXOY share price (ISIN: US68616W1027) to enhance your trading decisions with our free investment tools and resources.
What Is the Orexo AB ADR Share Price Today?
The Orexo ADR share price today is 2.65.
What Is the Stock Symbol for Orexo AB ADR
The stock symbol (or 'ticker') for Orexo AB ADR is "ORXOY."
What Stock Exchange Does Orexo AB ADR Trade On?
Orexo AB ADR is listed and trades on the OTC Markets stock exchange.
Is Orexo AB ADR a Good Stock to Buy?
Determining whether Orexo AB ADR—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Orexo AB ADR share price performance charts on this page. Our technical summary section provides analysis on Orexo ADR share price buy/sell indicators using real-time data (or discuss the Orexo ADR (ORXOY) stock price today with other investors in the Orexo ADR OTC share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current OTC ORXOY share price (ISIN: US68616W1027) to enhance your trading decisions with our free investment tools and resources.
What Is the Orexo AB ADR Share Price Today?
The Orexo ADR share price today is 2.65.
What Is the Stock Symbol for Orexo AB ADR
The stock symbol (or 'ticker') for Orexo AB ADR is "ORXOY."
What Stock Exchange Does Orexo AB ADR Trade On?
Orexo AB ADR is listed and trades on the OTC Markets stock exchange.
Is Orexo AB ADR a Good Stock to Buy?
Determining whether Orexo AB ADR—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
2.65
0.00(0.00%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.65
2.65
52 wk Range
1.91
4.05
ORXOY is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.652.65
52 wk Range
1.914.05
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ORXOY Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales decline in the current year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell
Orexo AB (publ), a pharmaceutical company, provides advance treatments for severe diseases and life-saving rescue medications in the United States, European Union, the United Kingdom, and internationally. Its products include Zubsolv tablets for the treatment of opioid use disorder; Abstral for the treatment of breakthrough pain in cancer patients; Edluar for the treatment of insomnia; and Diabact UBT for the treatment of diagnosis of Helicobacter pylori. The company is developing Izipry for opioid overdose; OX640 to treat anaphylaxis with powder-based epinephrine; OX390 for overdoses caused by a combination of life-threatening illicit drugs; OX125 for opioid overdose with powder-based nalmefene; OX472 for intranasal formulation of semaglutide, a GLP-1 receptor agonist, developed using proprietary AmorphOX technology; and develops thermostable and needle-free mucosal vaccines. Orexo AB (publ) was incorporated in 1994 and is headquartered in Uppsala, Sweden.
Compare ORXOY to Peers and Sector
Metrics to compare | ORXOY | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipORXOYPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.6x | 23.5x | −0.5x | |
PEG Ratio | 0.00 | 1.86 | 0.00 | |
Price/Book | 1.3x | 4.2x | 2.6x | |
Price / LTM Sales | 25.1x | 3.8x | 3.2x | |
Upside (Analyst Target) | - | 56.5% | 48.8% | |
Fair Value Upside | Unlock | 19.6% | 7.6% | Unlock |
Earnings
Latest Release
05/02/2026
EPS / Forecast
-- / --
Revenue / Forecast
3.3M / --
FAQ
What Is the Orexo ADR (OTC Markets: ORXOY) Share Price Today?
The Orexo ADR stock price today is 2.65 USD.
What Stock Exchange Does Orexo ADR (ORXOY) Trade On?
Orexo ADR is listed and trades on the OTC Markets.
What Is the Ticker (Stock Symbol) for Orexo ADR?
The stock symbol (also called a 'ticker') for Orexo ADR is "ORXOY."
What Is the Current Orexo ADR Market Capitalisation?
As of today, Orexo ADR (OTC Markets: ORXOY) market cap is 70.40M USD.
What Is Orexo ADR's (ORXOY) Earnings Per Share (TTM)?
The Orexo ADR EPS is currently -11.65 (Trailing Twelve Months).
Is ORXOY a Buy or Sell From a Technical Analyst Perspective?
Based on today's Orexo ADR moving averages and other technical indicators, the daily buy/sell signal for ORXOY stock is Neutral.
How Many Times Has Orexo ADR Stock Split?
Orexo ADR has split 0 times. (See the ORXOY stock split history page for full effective split date and price information.)
How Many Employees Does Orexo ADR Have?
Orexo ADR has 74 employees, based on their latest Companies House report.
What is the current trading status of Orexo ADR (OTC Markets: ORXOY)?
As of 29/04/2026, Orexo ADR (ORXOY) is trading at a share price of 2.65 USD, with a previous close of 2.65 USD. The stock has fluctuated within a day range of 2.65 USD to 2.65 USD, while its 52-week range spans from 1.91 USD to 4.05 USD.
Industry Spotlight
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.